Funding for this research was provided by:
Horizon 2020 (825825)
Fundación Ramón Areces (Advanced gene editing technologies to restore LAMA2 on merosin-deficient congenital muscular dystrophy type 1A)
Agencia Estatal de Investigación (CEX2018-000792-M)
Received: 8 September 2021
Accepted: 30 September 2022
First Online: 25 October 2022
: All animal procedures were approved by the Animal Experimentation ethics committee of Barcelona Biomedical Research Park (protocol number MGC2-19-0033-P2).
: The authors declare no competing interests.